Clinical Trial Update: Trial of Mesalamine for the Treatment of Active Microscopic Colitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials of mesalamine for active microscopic colitis have been completed. The study is sponsored by Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Microscopic Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Microscopic Colitis, Diarrhea | Phase 2, Phase 3 | Status: COMPLETED